Brief: Mankind Pharma Approved Issue Of Non-Convertible Debentures For Upto 50 Bln Rupees
30/09/2024 07:56
Sept 30 (Reuters) - Mankind Pharma Ltd MNKI.NS :
* MANKIND PHARMA - APPROVED ISSUE OF NON-CONVERTIBLE
DEBENTURES
FOR UPTO 50 BILLION RUPEES
* MANKIND PHARMA - APPROVED ISSUE OF COMMERCIAL PAPER FOR
UPTO 50
BILLION RUPEES
Source text for Eikon: ID:
Further company coverage: MNKI.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mankind Pharma
See all newsIndia's Mankind Pharma heads for best day in over 3 years as Q2 hints at recovery
Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand
India's Mankind Pharma gains on higher quarterly profit
Brief: Mankind Pharma Says To Buy 70% Majority Stake In Armed Cell Therapeutics Through Unit
Kotak upgrades India's Mankind Pharma to 'buy' on signs of business recovery